SHF-1036

N/A

Report date: 2025/01/26 16:12:23
NME

Base Information

Drug NameSHF-1036
Drug Alias NameAM2R antagonists (University of Sheffield/Modulus Oncology)adrenomedullin-2 receptor antagonists (Modulus Oncology)SHF-1036
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenomedullin receptor inhibitors
TargetsAdrenomedullin receptor
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Sheffield
China Registration ClassN/A

Develop Information

Active CompaniesModulus Oncology Ltd
Inactive CompaniesUniversity Of Sheffield
Active IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A